Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 January 2019 | Story Mamosa Makaya | Photo Xolisa Mnukwa
Nkahiseng
Nkahiseng Ralepeli will join the Rhodes Scholarship cohort of 2019.

Aspiring lawyer and political prodigy, Nkahiseng Ralepeli, will soon join a cohort of Rhodes Scholarship recipients at the University of Oxford in the UK later this year. He completed his LLB at the University of the Free State (UFS) in 2018, and it comes as no surprise that this young achiever has his eyes set on greater heights.

As a student, Nkahiseng was always a cut above the rest, with his involvement in non-governmental organisations such as Corruption Watch and Debate Afrika, where he used debating to not only educate youth in South Africa but to engage various social ills that plague the country in whichever way he could. He represented the UFS at various debating tournaments such as the Pan-African Universities Debating Championships and the World Universities Debating Championships.

“This is something I’ve wanted for an incredibly long time. Receiving this scholarship is so important, and makes me feel that all my efforts and work have been validated. What I’ve learned is that regardless of the situation you’re born into, rich or poor, hard work is rewarded. I hope this experience will help me realise my dreams and career goals, but most importantly I want to have a significant impact in whatever space I find myself in and on the people I encounter,” said Nkahiseng.

As an Abe Bailey Bursary recipient, he is deeply interested in the transformation of African political theory and the establishment of various structures in the development and maintenance of African ‘infant’ democracies and post-civil wars. He later hopes to pursue a career in South African politics. His list of achievements keeps getting longer as he adds to it the Rhodes Scholarship. The UFS is truly proud to have an alumnus of this high calibre.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept